Impute Inc.
Hirofumi Hamanaka has experience in various leadership roles in the pharmaceutical and healthcare industry. Currently serving as Vice President of Health Care at Impute Inc., Hirofumi also holds the title of Representative of Japan office at Shanghai LISOR Pharmaceutical Technology Co., a subsidiary of China Sino Pharma Group. Additionally, Hirofumi is the CEO of Veras Research Japan Ltd. / ACA (Asia CRO Alliance) Organizer. With a background as the Japan Representative at Chiltern Japan and Senior Vice President at Japan Domestic CRO, Hamanaka has a wealth of experience in the industry.
This person is not in any teams
Impute Inc.
Welcome to IMPUTE. IMPUTE Inc, is working on AI solution for neurological disorders such as Autism Spectrum Disorder (ASD), ADHD and language delay. We are developing AI based digital therapy for neurological disorders. Our digital therapy for ASD can be used in comfort of home and based on deep data mining can be customized for each individual need and learning habits. We do hope our digital therapy will be a great help to improving life and society.